RE: Growing market7 Sep 2022 13:41
This is what really gets my goat with this company. How are they allows to continually get away with examples such as this.
April RNS
Abingdon has received initial purchase orders from Vatic for commercial sale, and manufacturing for these orders will now commence.
Most recent update.
Company continues to work closely with Vatic as they progress their US FDA Emergency Use Approval ("EUA") and awaits the key reagent from Vatic to begin the manufacturing of the devices